Kwality Pharmaceuticals has informed that the meeting of the Board of Directors of the company is scheduled to be held on November 14, 2016, to consider the Standalone and Consolidated Unaudited Financial Results of the Company for the half year ended on September 30, 2016.
Further, in accordance with the Companys Code of Conduct for Prohibition of Insider Trading framed pursuant to the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015, the Trading window for dealing in securities of the company for all the Directors(s) and Designated Employee(s) of the company will remain closed from November 07, 2016 to November 16, 2016 (both days inclusive).
The above information is a part of company’s filings submitted to BSE.
